Newsbenzinga
Canadian Approval Of Lipocine Drug Marks Progress for Oral Testosterone Options In Canada
· Published
Article summary
Canada approves Lipocine’s TLANDO for adult males with testosterone deficiency. Partner Verity Pharma plans a launch by the end of 2026.
An excerpt from the original article.
Comments —
Loading comments…